Dermatomyositis induced by anti-tumor necrosis factor in a patient with juvenile idiopathic arthritis

JAMA Dermatology

Volumn 149, Issue 10, 2013, Pages 1204-1208

  Liu, Stephanie W ^a   Velez, Nicole F ^a   Lam, Christina ^a   Femia, Alisa ^a   Granter, Scott R ^a   Townsend, Henry B ^b   Vleugels, Ruth Ann ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b The University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; DICLOFENAC; ETANERCEPT; METHOTREXATE; PREDNISONE; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARM DISEASE; ARTHRALGIA; ARTICLE; CASE REPORT; CHILDHOOD; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; ERYTHEMA; EYELID ERYTHEMA; FACE DISORDER; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LIMB DISEASE; LONG TERM CARE; LOW DRUG DOSE; MALE; MEDICAL HISTORY; MEDICATION COMPLIANCE; PAPULE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PUNCH BIOPSY; RASH; RECURRENT DISEASE; SKIN BIOPSY; SKIN PRURITUS; SKIN SWELLING; SUN EXPOSURE; THORAX DISEASE;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE; DERMATOMYOSITIS; DRUG ERUPTIONS; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885902848     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.5220     Document Type: Article

References (15)

1. Ramos-CasalsM, Perez-Alvarez R, Diaz-Lagares C, Cuadrado M-J, Khamashta MA; BIOGEAS Study Group. Autoimmune diseases induced by biological agents: a double-edged sword? Autoimmun Rev. 2010;9(3): 188-193.
2. Ramos-CasalsM, Brito-Zeron P, SotoM-J, Cuadrado M-J, KhamashtaMA. Autoimmune diseases induced by TNF-targeted therapies. Best Pract Res Clin Rheumatol. 2008;22(5): 847-861.
3. Klein R, Rosenbach M, Kim EJ, Kim B,Werth VP, Dunham J. Tumor necrosis factor inhibitor-associated dermatomyositis. Arch Dermatol. 2010;146(7): 780-784.
4. Moustou AE, Matekovits A, Dessinioti C, Antoniou C, Sfikakis PP, Stratigos AJ. Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review. J AmAcad Dermatol. 2009;61(3): 486-504.
5. Riolo G, Towheed TE. Anti-tumor necrosis factor inhibitor therapy-induced dermatomyositis and fasciitis. J Rheumatol. 2012;39(1): 192-194.
6. Brunasso AM, Scocco GL, Massone C. Dermatomyositis during adalimumab therapy for rheumatoid arthritis. J Rheumatol. 2010;37(7): 1549-1550.
7. Hall HA, Zimmermann B. Evolution of dermatomyositis during therapy with a tumor necrosis factor α inhibitor. Arthritis Rheum. 2006;55(6): 982-984.
8. Ishikawa Y, Yukawa N, Ohmura K, et al. Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature. Clin Rheumatol. 2010;29(5): 563-566.
9. Musiał J, Undas A, Celińska-LowenhoffM. Polymyositis associated with infliximab treatment for rheumatoid arthritis. Rheumatology (Oxford). 2003;42(12): 1566-1568.
10. Urata Y,Wakai Y, Kowatari K, Nitobe T, Mizushima Y. Polymyositis associated with infliximab treatment for rheumatoid arthritis. Mod Rheumatol. 2006;16(6): 410-411.
11. Ishikawa Y, Yukawa N, Kawabata D, et al. A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept. Clin Rheumatol. 2011;30(3): 429-432.
12. Ishiguro T, Takayanagi N, Miyahara Y, Yanagisawa T, Sugita Y. Antisynthetase (anti PL-7 antibody) syndrome presenting as a skin rash and exacerbation of interstitial pneumonia during treatment for rheumatoid arthritis [in Japanese]. Nihon Kokyuki Gakkai Zasshi. 2010;48(3): 240-246.
13. Martinez-Cordero E, Leon DE, Ortega LA. Association of polymyositis with rheumatoid arthritis. Rheumatol Int. 2001;20(3): 119-123.
14. Nagashima T, Minota S. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy [letter]. J Rheumatol. 2011;38(3): 574-575.
15. Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyositis sine myositis): presentation of six new cases and review of the literature. J AmAcad Dermatol. 1991;24(6, pt 1): 959-966.